Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1998-01-06
1999-12-21
Moezie, M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
424452, 424465, A61K 31335, A61K 948, A61K 920
Patent
active
060049960
ABSTRACT:
Product containing tetrahydrolipstatin as the active ingredient and pharmaceutically acceptable excipients, characterized in that it is in the form of particles with a diameter of 0.25 to 2 mm; and pharmaceutical preparation s or compositions for oral administration containing the product.
REFERENCES:
patent: 4598089 (1986-07-01), Hadvary et al.
patent: 5540917 (1996-07-01), Isler et al.
patent: 5643874 (1997-07-01), Bremer et al.
CAPLUS abstract, AN 1995: 422878, Bremer et al. (EP 638 317 A1), (1995).
J.W. Connie and H.R. Hadley, D&CI, Apr. 19970, pp. 38-41.
A. D. Reynolds, Manufacturing Chemist & Aerosol News, Jun. 1970, pp. 40-43.
C.W. Woodruff & N.O. Nuessle, J. Pharm. Sci. 61(5), pp. 787-790 (1972).
H.J. Malinowski & W.E. Smith, J. Pharm. Sci. 64(10), pp. 1688-1692 (1975).
Digestion 52(2) 82-83, 1992, Fried. M.
Diabetologia 36 (Suppl. 1) Abstract A184, 1993, No. 706.
Diabetes Care (USA) 19/11, pp. 1311-1315 (1996).
Diabetes Care (USA) 18/8, pp. 1215-1219 (1995).
Shah Navnit Hargovindas
Zeller Max
Epstein William H.
Hoffman-La Roche Inc.
Johnston George W.
Moezie M.
Parise John P.
LandOfFree
Tetrahydrolipstatin containing compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tetrahydrolipstatin containing compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tetrahydrolipstatin containing compositions will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-505659